Effect of naloxone on body temperature in postmenopausal women with Parkinson's disease.
The role exerted by the endogenous opioid system on thermoregulation has been studied in six postmenopausal women affected by Parkinson's disease and in 6 age-matched, normal postmenopausal women, as controls. The women randomly received an infusion of the opioid antagonist naloxone (1.6 mg/h for 4 h) or of saline on two consecutive days. Body temperature, as evaluated by rectal temperature, was significantly lower (p less than 0.05) in Parkinsonian than in normal women, and it did not vary during saline infusion, in either groups. Naloxone infusion significantly reduced (p less than 0.01) body temperature in normal postmenopausal women, but it was unable to modify body temperature in women affected by Parkinson's disease. The low basal body temperature values and the inability of naloxone to exert a hypothermic effect in women suffering from Parkinson's disease seem to constitute further evidence for an impaired regulation of body temperature and impaired activity of the endogenous opioid system in this pathology.
Cagnacci
A
A
Department of Obstetrics and Gynecology, University of Pisa, Italy.
Bonuccelli
U
U
Melis
G B
GB
Soldani
R
R
Piccini
P
P
Napolitano
A
A
Muratorio
A
A
Fioretti
P
P
D000368:Aged; D000704:Analysis of Variance; D001833:Body Temperature Regulation / Q000187:drug effects*; D002940:Circadian Rhythm; D004723:Endorphins / Q000502:physiology; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008593:Menopause; D008875:Middle Aged; D009270:Naloxone / Q000008:administration & dosage / Q000494:pharmacology*; D010300:Parkinson Disease / Q000503:physiopathology*; D011897:Random Allocation
D004723:Endorphins; D009270:Naloxone